CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
CANbridge Pharmaceuticals Inc. has announced the resignation of Mr. Glenn Hassan as Chief Financial Officer effective September 30, 2024, for personal reasons, with no disagreements reported with the board. CEO Dr. James Qun Xue will cover the CFO role on an interim basis, supported by the finance team, until a new CFO is appointed. The company expressed appreciation for Mr. Hassan’s contributions during his tenure.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.